Development and internal validation of a screening tool for chronic prostatitis (S-CP)
-
By
-
Yoichiro Tohi
-
Yasukazu Hijikata
-
Mikio Sugimoto
-
Hideya Kuroda
-
Mineo Takei
-
Takakazu Matsuki
-
Tsukasa Kamitani
-
Yoshiyuki Kakehi
-
Shunichi Fukuhara
-
Yosuke Yamamoto
-
September 15, 2023
-
Clinical Scorecard: Creation and internal assessment of a screening instrument for chronic prostatitis (S-CP)
At a Glance
| Category | Detail |
|---|
| Condition | Chronic prostatitis/chronic pelvic pain syndrome (CP), NIH category III |
| Key Mechanisms | Pelvic pain, discomfort, dysuria; symptom flares triggered by cold, sitting/driving, stimulants/alcohol, lack of sleep/stress |
| Target Population | Men aged 20 to 84 years in the general population |
| Care Setting | Primary care and urology clinics |
Key Highlights
- CP affects 1.8–9.7% of men and significantly impairs quality of life across age groups.
- Diagnosis is complex with no definitive test; relies on exclusion by experienced urologists.
- Developed S-CP, a self-checkable screening tool based on three domains: pain area, accompanying symptoms, and symptom triggers.
Guideline-Based Recommendations
Diagnosis
- Comprehensive diagnosis by experienced urologists excluding other urological disorders is gold standard.
- Use of S-CP screening tool to identify individuals in general population who may have CP and encourage urologist consultation.
Management
- Appropriate treatment should be provided once diagnosis is confirmed; early identification via screening may improve outcomes.
Monitoring & Follow-up
- Monitor symptom severity and quality of life impact; NIH-CPSI can be used for symptom measurement but not screening.
Risks
- Risk of underdiagnosis and undertreatment due to diagnostic complexity and lack of screening tools.
- Symptom overlap with other urological conditions necessitates careful differential diagnosis.
Patient & Prescribing Data
Men aged 20–84 years with or without prior CP diagnosis in Japan general population
Many patients with CP-like symptoms remain undiagnosed; screening may increase appropriate treatment access.
Clinical Best Practices
- Utilize the S-CP screening tool comprising three domains: pain area, accompanying symptoms, and symptom triggers to identify potential CP cases.
- Encourage patients with positive screening results to seek urological evaluation for definitive diagnosis.
- Consider patient-reported symptom triggers and quality of life impact in clinical assessment.
- Apply comprehensive exclusion of other urological disorders before confirming CP diagnosis.
References
